Bio-Reference Laboratories Inc.‘s (BRLI) share price has entered into oversold territory with a stochastic value of 11.3723. The Zacks Consensus Estimate on the company’s earnings for year ending October 2012 increased by a cent over the past two months to $1.45 per share. Bio-Reference Laboratories Inc.is a Zacks #2 Rank (“Buy”) company.
To read this article on Zacks.com click here.
Zacks Investment Research
